• Regulatory NewsRegulatory News

    EMA's 2015 Annual Report: Interest in Scientific Advice Increasing

    The European Medicines Agency (EMA) on Tuesday released its Annual Report 2015 touting its performance and key achievements for the year. According to Sir Kent Woods, former chair of the EMA Management Board, 2015 was a year of transition for the agency. In November 2014, EMA Executive Director Guido Rasi's appointment was annulled , leaving the agency without a head until November of the following year when Rasi was re-appointed . Despite the disruption to EMA's le...
  • Regulatory NewsRegulatory News

    A Second Chance? EMA Board Nominates Guido Rasi to Lead Again

    The European Medicines Agency’s (EMA’s) Management Board on Thursday nominated Professor Guido Rasi as the executive director of the agency, a little less than a year after he was forced to step down from the position. Rasi has been invited to give a statement to the European Parliament’s Committee on the Environment, Public Health and Food Safety (ENVI) on 13 October 2015, and the appointment of the new executive director will be made after this session. The EMA told ...
  • Chair of UK’s MHRA Leaving

    Sir Gordon Duff, the chairman of the UK Medicines and Healthcare products Regulatory Agency (MHRA) announced on 27 March 2014 that he is giving up his position at the agency after his recent appointment as Principal of St Hilda's College, Oxford. The move is to take place "later this year" and the Department of Health has already initiated a recruitment process to find a successor for Sir Gordon. Prior to taking the position as chair of the MHRA in January 2013, Sir Go...
  • After Decade at MHRA, Breckenridge to Step Aside

    The UK's Medicines and Healthcare products Regulatory Agency (MHRA) will have a new chairman as of 1 January 2013, the agency has announced. Professor Sir Gordon Duff will assume the position of chairman of MHRA on the first of the new year, replacing outgoing Chairman Sir Alasdair Breckenridge, whose term ends on 31 December 2012. The transition is a significant one for MHRA, as Breckenridge has been chairman of the agency since its inception in April 2003. Prior to ...